Lataa...
Discovery of anti-MERS-CoV small covalent inhibitors through pharmacophore modeling, covalent docking and molecular dynamics simulation
Middle east respiratory syndrome coronavirus (MERS-CoV) is a fatal pathogen that poses a serious health risk worldwide and especially in the middle east countries. Targeting the MERS-CoV 3-chymotrypsin-like cysteine protease (3CL(pro)) with small covalent inhibitors is a significant approach to inhi...
Tallennettuna:
| Julkaisussa: | J Mol Liq |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier B.V.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8040153/ https://ncbi.nlm.nih.gov/pubmed/33867606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molliq.2021.115699 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|